A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative ...

This Research Topic is the second volume of the “Immune Responses Against Tumors - From the Bench to the Bedside” Community Series. Please see Volume I ...

Antigen-presenting cells (APCs), such as dendritic cells and macrophages, are essential for initiating and regulation of anti-tumor T cell responses.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

The aim of this study was to evaluate the prognostic value of undetectable circulating tumor DNA (ctDNA) and the dose-response relationship between ctDNA levels and survival outcomes in metastatic ...

Meanwhile, we analyzed the effect of RUNX2 isoform II overexpression or knockdown on OSCC cell ferroptosis or apoptosis, cell proliferation and tumor growth.

Role of adherent-to-suspension transition in melanoma metastatic dissemination and circulating tumor cell dynamics [abstract]. In: Proceedings of the American Association for Cancer Research Annual ...

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Circulating cell-free DNA (cfDNA ... probes to enhance hepatocellular carcinoma (HCC) detection [abstract ...

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...

High-intensity interval training (HIIT) shows promise in inhibiting cancer cell growth, particularly in prostate cancer. Studies reveal that even a single HIIT session can alter body chemistry ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Detection of tumour-derived DNA fragments in a patient's bodily fluids (circulating ... for stage II colon cancer. 2 An important remaining question is whether the detected post-surgical ctDNA ...